Calif. Prop 65 Warnings On Smoking Cessation Drugs Federally Preempted, Court Says
This article was originally published in The Pink Sheet Daily
Executive Summary
State-mandated warnings that OTC nicotine replacement therapies may "cause reproductive harm" directly conflict with FDA labeling requirements, California Supreme Court rules in a victory for drug manufacturers and the agency.